Across TCGA pan-cancer cohorts, ELOCP20 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of ELOCP20’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where ELOCP20 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ELOCP20 is over-expressed in tumor.

THCA are the cancer types where ELOCP20 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELOCP20 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	+1.415	<.001	9	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: ELOCP20 RNA expression & survival · all ELOCP20 data types